Virtual Events
JDRF’s Spring TypeOneNation Summit: Living Without Limits – Now Available On Demand!
On Saturday, April 24, the TypeOneNation Virtual Summit provided a jam-packed day of empowering diabetes education, inspirational speakers and virtual exhibits showcasing the latest in diabetes technology and management. The Summit covered a range of topics for all stages of life with T1D. There is no cost for this event and there are no limits to what you can learn at this year’s TypeOneNation Summit! If you missed it, don’t worry, all sessions were recorded and are available on demand through May 31, 2021.
Thank You to Our Sponsors
Premier Sponsor
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Supporting Sponsors
Abbott, the worldwide leader in Continuous Glucose Monitoring, has put a focus on helping people with diabetes lead healthier happier lives. They are dedicated to developing the next generation technologies that will provide glucose readings faster, with less inconvenience and help patients take charge of their diabetes. Start a New Chapter in Managing Your Diabetes with a FreeStyle Libre 2 free trial!
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. Get Started Today
ERinfo understands the challenges, struggles and stress that comes with T1D. ERinfo offers anywhere, anytime identification and contact notifications during emergency situations. We provide medical first responders access to your information through a direct connection to FirstNet®, the government’s nationwide broadband network that equips responders to save lives and protect you throughout the US. We are working with JDRF to educate the T1D community on the importance of using medical alerts. Be Prepared – Enroll Today with a 15% JDRF Discount!
The World’s Only Long-Term CGM System
Eversense provides continuous blood glucose monitoring for up to 90 days via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. With the Eversense 90-Day CGM System, you can actively manage your diabetes with flexibility and confidence.
Meet our Eversense Pioneers
At Xeris, makers of the Gvoke HypoPen, we believe that easy-to-use medicines can have a profound impact on the lives of patients and their families. That’s why we’re studying ready-to-use liquid glucagon, but that’s just the beginning. Learn how our technology is unlocking the potential of today’s medicines.
For more than 30 years, Medtronic has been helping people with diabetes.
Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health.
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone-related disorders, and obesity.
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform.
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.